Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 1;44(4):e8-e9.
doi: 10.1097/ICO.0000000000003794. Epub 2025 Jan 17.

Reply

Alejandro Arboleda  1   2   3 , N Venkatesh Prajna  4 , Muthiah Srinivasan  4 , Hazem Mousa  5 , Victor L Perez  5 , Jennifer Rose-Nussbaumer  2   3
Affiliations

Reply

Alejandro Arboleda et al. Cornea. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Financial disclosures/conflicts of interest: This work was supported in part by an unrestricted grant from Research to Prevent Blindness (RPB), National Eye Institute (NEI): center grant P30-EY026877 (Duke, Stanford), R01EY030283 (VLP), R01EY024485 (VLP), UG1 EY030417 (JRN), UG1 EY028518 (JRN), K23 EY025025 (JRN). Funding for the Steroids for Corneal Ulcers Trial (SCUT) was provided by the NEI U10 EY015114 (TML), K23 EY017897 (NRA), EY02162 (UCSF), and a Research to Prevent Blindness Award. SCUT was registered at clinicaltrials.gov (NCT00324168). Funding for the Mycotic Ulcer Treatment Trial (MUTT) I and II were provided by: U10 EY018573 (TML), K23 EY017897 (NRA), K23 EY025025 (JRN), grants from That Man May See, the Harper/Inglis Trust, the South Asia Research Foundation, and Research to Prevent Blindness. MUTT I was registered at clinicaltrials.gov (NCT00996736). MUTT II was registered at clinicaltrials.gov (NCT00997035). V.L. Perez has financial relationships with Alcon, Dompe, EyeGate, Kala, Trefoil, Novartis, and Oculis. The remaining authors have no conflicts of interest to disclose.

References

    1. Arboleda A, Prajna NV, Lalitha P, et al. Validation of the C-DU(KE) calculator as a predictor of outcomes in patients enrolled in steroids for corneal ulcer and mycotic ulcer treatment trials. Cornea. 2024;43:166–171.
    1. Wong R. Letter Regarding: Validation of the C-DU(KE) calculator as a predictor of outcomes in patients enrolled in steroids for corneal ulcer and mycotic ulcer treatment trials. Cornea. 2025;44:e8.
    1. Mousa HM, Feghali J, Song A, et al. C-DU(KE) calculator: a clinical tool for risk stratification in infectious keratitis. Cornea. 2023;42:298–307.
    1. Srinivasan M, Mascarenhas J, Rajaraman R, et al. Corticosteroids for bacterial keratitis: the steroids for corneal ulcers trial (SCUT). Arch Ophthalmol. 2012;130:143–150.
    1. Prajna NV, Krishnan T, Mascarenhas J, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmol. 2013;131:422–429.

LinkOut - more resources